Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection (Q24194546)

1

0 references

Juan Guillermo Perez

2

0 references

Olga Lucia Cortes

3

0 references

Adelina Riarte

4

0 references

Micah Pepper

5

0 references

Jose Antonio Marin-Neto

Cochrane Database of Systematic Reviews

6

0 references

publication date

27 May 2014

0 references

published in

0 references

cites work

PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Efficacy of benznidazol treatment for asymptomatic chagasic patients from state of Rio Grande do Sul evaluated during a three years follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Ethiologic treatment of acute and chronic Chagas' Disease [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Longitudinal study and specific chemotherapy in children with chronic Chagas' disease, residing in a low endemicity area of Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Fexinidazole: a potential new drug candidate for Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Evaluation and treatment of chagas disease in the United States: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Chagas disease: a new worldwide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Elimination of Chagas disease transmission: perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Treatment and seroconversion in a cohort of children suffering from recent chronic Chagas infection in Yoro, Honduras

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Lessons from a national survey of Chagas disease transmission risk in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Chagas' heart disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Pathophysiology of the heart in Chagas' disease: current status and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Commentary: Control of Chagas' disease: let's put people before vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003463.PUB2

[Etiological treatment of Chagas' disease]

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease

1 reference

12 December 2020

[The chemotherapy of infections produced by Trypanosoma cruzi]

1 reference

12 December 2020

1 reference

12 December 2020

[Combined treatment of Chagas' disease with Bayer 2502 and corticoid (experimental and clinical study)]

1 reference

12 December 2020

Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection

1 reference

12 December 2020

[Therapeutics of the chronic form of Chagas' disease. Specific treatment of Trypanosoma cruzi infection]

1 reference

12 December 2020

Treatment of chronic Chagas' disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up

1 reference

12 December 2020

Long term evaluation of etiological treatment of chagas disease with benznidazole.

1 reference

12 December 2020

[Specific treatment of Chagas' disease]

1 reference

12 December 2020

[Etiological treatment of Chagas disease. Consensus and divergence]

1 reference

12 December 2020

Experience with nifurtimox in chronic Chagas' infection. Preliminary report

1 reference

12 December 2020

Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution

1 reference

12 December 2020

Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries

1 reference

12 December 2020

[Chagas' disease in children and its treatment with Bay 2502]

1 reference

12 December 2020

[Current prospects of specific treatment of Chagas' disease]

1 reference

12 December 2020

The effect of nifurtimox in acute Chagas' infection

1 reference

12 December 2020

Treatment of Chagas disease with benznidazole and thioctic acid

1 reference

12 December 2020

Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients.

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of chronic human Chagas disease with itraconazole and allopurinol. Preliminary report

1 reference

12 December 2020

[Clinical and therapeutics aspects of heart failure due to Chagas disease]

1 reference

12 December 2020

[Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation]

1 reference

12 December 2020

Chemotherapy of Trypanosoma cruzi infections

1 reference

12 December 2020

Should benznidazole be used in chronic Chagas' disease?

1 reference

12 December 2020

[Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase]

1 reference

12 December 2020

Possibility of treatment in Chagas' disease

1 reference

12 December 2020

[Treatment of Chagas' disease]

1 reference

12 December 2020

Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease

1 reference

12 December 2020

Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy

1 reference

12 December 2020

Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research

1 reference

12 December 2020

[Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole]

1 reference

12 December 2020

Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction

1 reference

12 December 2020

Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease

1 reference

12 December 2020

Interventional study in the natural evolution of Chagas disease. Evaluation of specific antiparasitic treatment. Retrospective-prospective study of antiparasitic therapy

1 reference

12 December 2020

1 reference

12 December 2020

[Treatment of Chagas disease]

1 reference

12 December 2020

Nifurtimox: causal treatment of Chagas' disease

1 reference

12 December 2020

1 reference

12 December 2020

Chemotherapy of Chagas' disease

1 reference

12 December 2020

Treatment of chronic Chagas' disease with itraconazole and allopurinol.

1 reference

12 December 2020

Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice

1 reference

12 December 2020

Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease

1 reference

12 December 2020

Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives.

1 reference

12 December 2020

[Treatment of Trypanosoma cruzi infection in the indeterminate phase: experience and current guidelines in Argentina]

1 reference

12 December 2020

Chagas' disease; a clinical, epidemiologic, and pathologic study

1 reference

12 December 2020

Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up

1 reference

12 December 2020

Etiological drug treatment of human infection by Trypanosoma cruzi.

1 reference

12 December 2020

Variance imputation for overviews of clinical trials with continuous response

1 reference

12 December 2020

Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole

1 reference

12 December 2020

No association between persistence of the parasite and electrocardiographic evolution in treated patients with Chagas disease

1 reference

12 December 2020

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

1 reference

12 December 2020